arrow
BackJournal Details
E

ESMO Gastrointestinal Oncology

IF
Papers72
Citations
Journal Papers 72
Publication Date
A phase II study of pembrolizumab plus chemotherapy with short-course radiotherapy as induction treatment for unresectable locally advanced esophageal squamous cell carcinoma: PALADIN trial
delete2026-06-01
delete0
deleteOAAI
deleteOkemoto, D.; Kotani, D.; Nakamura, M.; Sato, K.; Kubo, Y.; Kadota, T.; Mishima, S.; Sakashita, S.; Hashimoto, T.; Bando, H.; Wakabayashi, M.; Rabinowitz, M.; Liu, M. C.; Jurdi, A.; Yamaguchi, T.; Nishikawa, H.; Shitara, K.; Yano, T.; Kojima, T.; Fujita, Takeo
deleteShare
deleteSave
Dose optimization of immune checkpoint inhibitors for gastrointestinal malignancies
delete2026-06-01
delete0
PREAI
deleteAlsina, M.; Beunza-Sola, M.; Fernandez-Montes, A.; Padron-Rodriguez, B.; de Castro, E. M.; Valencia-Soto, C. M.; Fleitas, T.; Arrazubi, V.; Lecumberri, A.; Caseda, I.; Agirre, B.; Lainez, N.; Arasanz, H.; Rivera, F.; Vera, R.
deleteShare
deleteSave
Immune checkpoint inhibitor-induced myocarditis with atrioventricular conduction abnormalities: a case report
delete2026-06-01
delete1
deleteOAAI
deleteStrijdhorst, A.; Opstal, T. S. J.; Robbers, L. F. H. J.; Labots, M.; van Laarhoven, H. W. M.
deleteShare
deleteSave
Evaluating incidence and mortality trends of early-onset colorectal cancer and adenoma in Belgium
delete2026-05-01
delete1
PREAI
deleteJanssens, S.; Van Herck, K.; Francart, J.; Van Gool, B.; Audibert, A.; Clinckaert, C.; Van Damme, N.; Haustermans, K.; Van Eycken, L.
deleteShare
deleteSave
Cost savings associated with the adoption of lower-dose everolimus in patients with advanced neuroendocrine tumors
delete2026-05-01
delete0
PREAI
deletede Almeida, G. R.; Riechelmann, R. P.; Brito, A. B.; Taboada, R. G.; da Silva, A. L. M.; Weschenfelder, R. F.; Etges, A. P. B. S.
deleteShare
deleteSave
ENVELOPE: enfortumab vedotin in patients with advanced small bowel adenocarcinoma refractory or intolerant to platinum-based therapy―phase II investigator-initiated trial (NCCH2412/MK015)
delete2026-04-01
delete0
PREAI
deleteFujii, H.; Hirano, H.; Kudo, T.; Tsuchihashi, K.; Shoji, H.; Okita, N.; Hirose, T.; Takashima, A.; Yokoyama, M.; Kawasaki, M.; Shuda, Y.; Naito, M.; Ichikawa, K.; Sekine, K.; Sato, J.; Yamamoto, N.; Kato, K.
deleteShare
deleteSave
A pragmatic phase II trial evaluating treatment strategies using immune checkpoint inhibitors for metastatic esophageal cancer patients with severe dysphagia
delete2026-03-01
delete0
PREAI
deleteNagata, Y.; Arai, H.; Izawa, N.; Inagaki, C.; Sugaya, A.; Hirata, K.; Tsushima, T.; Moriwaki, T.; Masuishi, T.; Nagatani, Y.; Harada, K.; Taguri, M.; Sunakawa, Y.
deleteShare
deleteSave
A prospective, multicenter, observational study of trastuzumab deruxtecan in elderly patients with HER2-positive gastric cancer: EN-COURAGE
delete2026-03-01
delete0
PREAI
deleteNarita, Y.; Kawabata, R.; Ando, T.; Arigami, T.; Kawakami, H.; Makiyama, A.; Uozumi, R.; Fukuda, Y.; Muro, K.
deleteShare
deleteSave
Continuous Imaging to Evaluate Growth and Drug Responses of Patient-Derived Colorectal Tumouroids (vol 7, 100137, 2025)
delete2026-03-01
delete0
PREAI
deleteSakshaug, B. C.; Folkesson, E.; Haukaas, T. H.; Sigfusdottir, M. S.; Troen, H. H.; Sperstad, S. B.; Bwanika, H. C. H.; Ringers, C.; Bergstrom, I. A.; Klinkenberg, G.; Visnes, T.; Flobak, A.
deleteShare
deleteSave
Preference versus protocol: oncology clinicians' perspectives on central venous access for administration of chemotherapy in pancreatic cancer
delete2026-03-01
delete0
PREAI
deleteGraus, M. U. J. E.; Willems, R. A. L.; Biesma, N. C.; de Wilde, A. J.; van den Berkmortel, F. W. P. J.; Bouwense, S. A. W.; Cirkel, G. A.; Homs, M. Y., V; Jellema-Betten, E.; Pepels-Aarts, N.; van Santvoort, H. C.; van Vliet, E. C. J.; Wumkes, M. L.; Wilmink, J. W.; de Hingh, I. H. J. T.; Valkenburg-van Iersel, L. B. J.; de Vos-Geelen, J.
deleteShare
deleteSave
Fruquintinib in combination with tislelizumab versus trifluridine/tipiracil and bevacizumab in third-line and beyond MSS mCRC without active liver metastases―the IKF-080/AIO-QUINTIS trial
delete2026-03-01
delete0
PREAI
deleteTintelnot, J.; Gorgulho, J.; Al-Batran, S. -E.; Arnold, D.; Reinacher-Schick, A.; Kasper, S.; Prager, G.; Goetze, T.; Boston, R.; Cruz, M. S.; Dierks, F.; Stein, A.
deleteShare
deleteSave
Revisiting cholesterol metabolism in hepatocellular carcinoma: a hidden driver of systemic therapy response
delete2026-02-01
delete0
PREAI
deleteStoffels, L. M.; Rodriguez, E. S. Espinoza; Theys, J.; Shiri-Sverdlov, R.
deleteShare
deleteSave
Clinical and translational results from the phase II ABACO trial evaluating the activity of cabozantinib in pretreated patients with metastatic colorectal cancer
delete2026-02-01
delete0
deleteOAAI
deleteDe Falco, V.; Vitiello, P. P.; Ciardiello, D.; Grasso, G.; Mariella, E.; Martini, G.; Napolitano, S.; Cardone, C.; Arrichiello, G.; Varriale, E.; Di Bisceglie, M.; Latiano, T.; Maiello, E.; Reginelli, A.; Brunese, M. C.; Cappabianca, S.; Del Tufo, S.; Orlando, A.; Nicastro, A.; Caraglia, F.; Esposito, L.; Renato, D.; Avallone, A.; Orditura, M.; Fazio, N.; Curigliano, G.; Zampino, M. G.; Bardelli, A.; Ciardiello, F.; Troiani, T.; Martinelli, E.
deleteShare
deleteSave
Readministration of nivolumab for patients with advanced gastric cancer: a case series
delete2026-02-01
delete0
deleteOAAI
deleteKodama, H.; Narita, Y.; Honda, K.; Masuishi, T.; Taniguchi, H.; Kadowaki, S.; Ando, M.; Tajika, M.; Yamaguchi, T.; Nishikawa, H.; Muro, K.
deleteShare
deleteSave